The Antibiotic Development Pipeline for Multidrug-Resistant Gram-Negative Bacilli: Current and Future Landscapes

被引：14
|
作者：
Talbot, George H. [1 ]
机构：
[1] Talbot Advisors LLC, Wayne, PA USA
来源：
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | 2010年 / 31卷
关键词：
DRUGS;
D O I：
10.1086/655988
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Development of antibiotics to treat infections caused by multidrug-resistant gram-negative bacilli has lagged significantly behind development of antibiotics to treat infections with gram-positive pathogens. Although a few promising drugs have entered early clinical development, more must be done to preserve the utility of currently available antibiotics and to ensure a pipeline of efficacious, safe antibacterials.
引用
收藏
页码：S55 / S58
页数：4
相关论文
共 50 条
  • [1] Current Epidemiology of Multidrug-Resistant Gram-Negative Bacilli in the United States
    Kallen, Alexander J.
    Srinivasan, Arjun
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 : S51 - S54
  • [2] The current state of multidrug-resistant gram-negative bacilli in north America
    Nicasio, Anthony M.
    Kuti, Joseph L.
    Nicolau, David P.
    PHARMACOTHERAPY, 2008, 28 (02): : 235 - 249
  • [3] A γ-Lactam Siderophore Antibiotic Effective against Multidrug-Resistant Gram-Negative Bacilli
    Goldberg, Joel A.
    Ha Nguyen
    Kumar, Vijay
    Spencer, Elizabeth J.
    Hoyer, Denton
    Marshall, Emma K.
    Cmolik, Anna
    O'Shea, Margaret
    Marshall, Steven H.
    Hujer, Andrea M.
    Hujer, Kristine M.
    Rudin, Susan D.
    Domitrovic, T. Nicholas
    Bethel, Christopher R.
    Papp-Wallace, Krisztina M.
    Logan, Latania K.
    Perez, Federico
    Jacobs, Michael R.
    van Duin, David
    Kreiswirth, Barry M.
    Bonomo, Robert A.
    Plummer, Mark S.
    van den Akker, Focco
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (11) : 5990 - 6002
  • [4] Multidrug-Resistant Gram-Negative Bacilli: Infection Control Implications
    Adler, Amos
    Friedman, N. Deborah
    Marchaim, Dror
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2016, 30 (04) : 967 - +
  • [5] Facing the challenge of multidrug-resistant gram-negative bacilli in Australia
    Harris, Patrick
    Paterson, David
    Rogers, Benjamin
    MEDICAL JOURNAL OF AUSTRALIA, 2015, 202 (05) : 243 - +
  • [6] Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections
    Bassetti, Matteo
    Garau, Javier
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 : IV23 - IV37
  • [7] Save Carbapenem Campaign: Assessment of Antibiotic Combinations Against Multidrug-Resistant Gram-Negative Bacilli
    Tellis, Rouchelle
    Ignatius, Anand
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S381 - S381
  • [8] Carriage of multidrug-resistant Gram-negative bacilli: duration and risk factors
    Herrera, S.
    Torralbo, B.
    Herranz, S.
    Bernal-Maurandi, J.
    Rubio, E.
    Pitart, C.
    Fortes, I.
    Valls, S.
    Rodriguez, L.
    Santana, G.
    Bodro, M.
    Garcia-Vidal, C.
    Hernandez-Meneses, M.
    Puerta, P.
    Morata, L.
    Villella, A.
    Bertran, M. J.
    Brey, M.
    Soriano, A.
    Del Rio, A.
    Martinez, J. A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023, 42 (05) : 631 - 638
  • [9] Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremia
    Patolia, Swati
    Abate, Getahun
    Patel, Nirav
    Patolia, Setu
    Frey, Sharon
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2018, 5 (01) : 11 - 18
  • [10] New treatments for multidrug-resistant nonfermenting Gram-negative bacilli Infections
    Chumbita, Mariana
    Monzo-Gallo, Patricia
    Lopera-Marmol, Carlos
    Francesco Aiello, Tommaso
    Puerta-Alcalde, Pedro
    Garcia-Vidal, Carolina
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 : 51 - 53
12345